drugset / Trial / NCT04532567

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Healthy Japanese and Caucasian Male Subjects

NCT04532567

Phase 1 Completed 32 enrolled Lakefront Biotherapeutics NV
RandomizedParallel-groupQuadruple-blindBasic science

Summary

The purpose of this research study is to assess the safety and tolerability of GLPG1205 in single and multiple oral doses in healthy male Caucasian and Japanese subjects. This study will also assess the pharmacokinetics (PK) across different doses of GLPG1205. PK will look at how the study drug is absorbed, broken down, and eliminated by your body.

Timeline

Start
2020-08-18
Primary completion
2020-12-10
Completion
2020-12-10

Drugs

EvaluationDrugModalityDoseRoute
Subject GLPG1205 Small molecule Oral

Indications

No indication recorded.